Aldose reductase deficiency leads to oxidative stress-induced dopaminergic neuronal loss and autophagic abnormality in an animal model of Parkinson's disease
| Autor: | Sookja K. Chung, Angela K. W. Lai, Onyou Hwang, Patrick Ka Kit Yeung, Hyo Jin Son, Xu Zhang, Stephen S.M. Chung |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Male
0301 basic medicine Aging medicine.medical_specialty Mice Transgenic Peroxiredoxin 2 Fidarestat 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Aldehyde Reductase Dopamine Internal medicine Autophagy medicine Animals Cells Cultured biology Tyrosine hydroxylase Chemistry Dopaminergic Neurons General Neuroscience MPTP Dopaminergic Parkinson Disease Tetrahydrobiopterin Mice Inbred C57BL Nitric oxide synthase Disease Models Animal Oxidative Stress 030104 developmental biology Endocrinology biology.protein Neurology (clinical) Geriatrics and Gerontology 030217 neurology & neurosurgery Developmental Biology medicine.drug |
| Zdroj: | Neurobiology of Aging. 50:119-133 |
| ISSN: | 0197-4580 |
| DOI: | 10.1016/j.neurobiolaging.2016.11.008 |
| Popis: | Fungicide exposure causes degeneration of dopaminergic neurons and contributes to Parkinson's disease (PD). Benomyl inhibits enzymes responsible for detoxifying the reactive dopamine metabolite 3,4-dihydroxyphenylacetaldehyde. Aldose reductase (AR) is known as tetrahydrobiopterin (BH4) reductase that generates BH4, a cofactor for tyrosine hydroxylase (TH) involved in dopamine synthesis. AR also acts as an aldehyde reductase involved in detoxifying 3,4-dihydroxyphenylacetaldehyde. In PD patients, the level of AR is significantly lower in the cerebellum. To determine if AR deficiency contributes to PD, AR wild-type (AR+/+) and knockout (AR-/-) mice were administrated with 1-methyl-4-phenyl -1,2,3,6- tetrahydropyridine (MPTP). The MPTP-treated AR-/- mice showed more severe behavioral deficits and brain damage than that of AR+/+ mice. Contrary to expectation, under normal or MPTP-treated condition, AR-/- mice showed a significant elevation of BH4 and dopamine in the midbrain, suggesting that either AR does not contribute to BH4 production, or other BH4 synthetic pathways are induced. The AR-/- brain showed upregulation of peroxynitrite, inducible nitric oxide synthase and downregulation of antioxidant enzymes, Cu/Zn superoxide dismutase (SOD) and peroxiredoxin 2 (Prx2), which indicate an increase in oxidative stress. In line with the animal data, pretreating the SH-SY5Y cells with AR inhibitors (Fidarestat or Epalrestat) before MPP+ treatment, increased severe cell death and mitochondrial fragmentation with downregulation of SOD were observed when compared to the MPP+ treatment alone. Cycloxygenase 2 (COX2), which can lead to the oxidation of dopamine, was upregulated in AR-/- brains. Autophagic proteins, beclin-1 and LC3B were also downregulated. The loss of dopaminergic neurons was associated with activation of p-ERK1/2. These findings suggest that AR plays an important role in protecting dopaminergic neuron against neurotoxic metabolites in PD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect